Evidence map›Paper›PMID 37663051›Full record

ArticleJournal of immunology research2023

Sesamin Protects against APAP-Induced Acute Liver Injury by Inhibiting Oxidative Stress and Inflammatory Response via Deactivation of HMGB1/TLR4/NF

Hui Du, Shiwen Tong, Ge Kuang, Xia Gong, Ningman Jiang, Xian Yang, Hao Liu, Nana Li, Yao Xie, Yang Xiang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. The potential of curcumin in mitigating acetaminophen-induced liver damage.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  7. Article
  8. HMGB1: key mediator in digestive system diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  9. Emerging Roles of High-mobility Group Box-1 in Liver Disease.Journal of clinical and translational hepatology · 2024
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Hui DuDepartment of Pharmacology, Chongqing Medical University, Chongqing, China.ORCID https://orcid.org/0000-0002-1645-028X
Shiwen TongDepartment of Clinical Nutrition, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Ge KuangDepartment of Pharmacology, Chongqing Medical University, Chongqing, China.
Xia GongDepartment of Anatomy, Chongqing Medical University, Chongqing, China.ORCID https://orcid.org/0000-0003-3407-1061
Ningman JiangDepartment of Pharmacology, Chongqing Medical University, Chongqing, China.
Xian YangDepartment of Pharmacology, Chongqing Medical University, Chongqing, China.ORCID https://orcid.org/0000-0001-8730-1479
Hao LiuDepartment of Pharmacology, Chongqing Medical University, Chongqing, China.
Nana LiDepartment of Pharmacology, Chongqing Medical University, Chongqing, China.
Yao XieDepartment of Pharmacology, Chongqing Medical University, Chongqing, China.
Yang XiangDepartment of Pharmacology, Chongqing Medical University, Chongqing, China.
Jiashi GuoDepartment of Pharmacology, Chongqing Medical University, Chongqing, China.
Zhenhan LiChongqing Traditional Chinese Medicine Hospital, Chongqing, China.
Yinglin YuanClinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Shengwang WuDepartment of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China.
Jingyuan WanDepartment of Pharmacology, Chongqing Medical University, Chongqing, China.ORCID https://orcid.org/0000-0002-1773-6474
Chongqing Medical University · CNArmy Medical University · CNDalian Medical University · CNFirst People's Hospital of Chongqing · CNUniversity of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetaminophen (APAP) overdose would lead to liver toxicity and even acute liver failure in severe cases by triggering an inflammatory response and oxidative stress. Sesamin has been reported to possess anti-inflammatory and antioxidant actions in several animal disease models. In the present study, the effects and mechanisms of sesamin on APAP-induced acute liver injury (ALI) were explored. The results showed that pretreatment with sesamin significantly alleviated APAP-induced ALI, as indicated by decreased serum aminotransferase activities, hepatic pathological damages, and hepatic cellular apoptosis. But sesamin has no significant effects on the expression of cytochrome P450 2E1 (CYP2E1), APAP-cysteine adducts (APAP-CYS) production, and glutathione content in the liver of APAP-administered mice. Moreover, APAP-induced liver oxidative stress and inflammatory response also were remarkedly attenuated by sesamin, including reducing hepatic reactive oxygen species levels, promoting antioxidant generation, and inhibiting the expression of TNF-

Indexed as

HMGB1 ProteinNF-kappa BAcetaminophenAnimalsAntioxidantsDioxolesLignansLiverMiceOxidative StressToll-Like Receptor 4AcetaminophenAntioxidantsDioxolesHMGB1 ProteinLignansNF-kappa BsesaminToll-Like Receptor 4

Identifiers

PMID37663051
PMCPMC10471453
OpenAlexW4386121896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.